The effect of COVID-19 fear on hygiene behaviors in hemodialysis patients during the COVID-19 pandemic

Abstract

Aim: Current study aims to specify the fear levels and hygiene habits of hemodialysis (HD) patients infected or not infected with coronavirus disease 2019 (COVID-19) in the course of the COVID-19 pandemic. Material and Method: This study was performed between 15-30 April 2021 as a case-control study whose population consisted of 124 dialysis patients treated in the dialysis unit of Batman Education and Research Hospital. In the dialysis unit, while 25 HD patients who were not present with COVID-19 were included in the control group, 25 dialysis patients were diagnosed with COVID-19 and agreed to participate in the study were included in the case group. “Patient Descriptive Form”, “COVID-19 Hygiene Scale (CHS)” and “COVID-19 Fear Scale (CFS)” were used to collect the study data. Results: While the mean score of the Changing Hygiene Behaviors sub-dimension of the HD patients in the case group was 23.72±4.90; the mean score of the same sub-dimension belonging to the HD patients in the control group was determined as 22.40±5.25, and there was no statistically meaningful difference between the two groups. The mean CFS score of the HD patients in the case group was 13.60±7.92; while the mean CFS score of the HD patients in the control group was found to be 17.72±7.43. No statistically meaningful difference was observed between the two groups. Conclusion: The mean CFS and CHS scores of the HD patients in the control group were higher, but no statistically meaningful difference was observed between the two groups.

Keywords

• Fear levels
• Hygiene habits
• Hemodialysis
• Coronavirus disease 2019

References

1. Ates K, Süleymanlar G, Nurhan S. Ministry of health and Turkish society of nephrology joint report. National Nephrology, Dialysis and Transplantation Registry Report of Turkey 2019 Ankara 2020. https://nefroloji.org.tr/uploads/folders/file/registry_2019.pdf
2. Tanrıverdi MH. Kronik böbrek yetmezliği. Konuralp Med J 2010; 2: 27-32.
3. Gülbahar O, Özkaya M, Cirit M, Akçiçek F. Kronik diyaliz hastalarında cerrahi. Türk Nefroloji Diyaliz ve Transplantasyon Derg 1997: 1: 11-14.
4. Bilgiç N. Kronik böbrek hastalıkları ile diyaliz birimlerinde hemşirelerin maliyet-etkililik ve verimliliğe etkisi. Nefroloji Hemşireliği Dergisi 2020; 15: 23-29.
5. İnkaya AÇ. SARS-CoV-2: Mikrobiyolojik özellikler ve hastalığın immünpatogenezi. Topeli İskit A, Durusu Tanrıöver M, Uzun Ö. (Eds). Covid-19 Pandemi Raporu (20 Mart- 20 Kasım 2020). Uzerler Matbaası Ankara 2021; p. 15-22.
6. Acar D. Kronik Böbrek Yetmezliği Olan Hastalarda Tedaviye Uyumla İlişkili Faktörler: Anksiyete, Depresyon, Hastalık Algısı. Adnan Menderes Üniversitesi Sağlık Bilimleri Enstitüsü. Yükseklisans Tezi 2018.
7. Öneç K. Pandemi Sürecinde Nefroloji ve Hemodiyaliz Hastalarının Yönetimi – Düzce Üniversitesi Deneyimleri. Konuralp Med J 2020; 12: 383-5.
8. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.

9. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62.
10. Huang Y, Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res 2020; 288: 112954.
11. Guan WJ, Ni ZY, Hu Y, et al.; China Medical Treatment Expert Group for COVID-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382: 1708-20.
12. Ekim M, Er ZC, Zekey FS, Ekim H, Çiçekcioğlu F, Polat MF. COVID-19 hastalığının kardiyovasküler sisteme etkileri. YOBÜ Sağlık Bilimleri Derg 2020; 1: 27-34.
13. Sandalcı B, Uyaroğlu OA, Güven GS. COVID-19’da kronik hastalıkların rolü, önemi ve öneriler. Flora 2020; 25: 1-7.
14. Kara B. One of the priority ıssues in patients with end-stage renal failure undergoing hemodialysis: quality of life. TAF Prev Med Bull 2012; 11: 631-8.
15. Imamah NF, Lin HR. Palliative care in patients with end-stage renal disease: a meta synthesis. Int J Environ Res Public Health 2021; 18: 10651.
16. Varol E, Sivrikaya SK. Kronik böbrek yetmezliğinde yaşam kalitesi ve hemşirelik. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Derg 2018; 8: 89-96.
17. Chilcot J, Wellsted D, Da Silva-Gane M, Farrington K. Depression on dialysis. Nephron Clin Pract 2008; 108: c256-64.
18. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, Pakpour AH. The Fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict 2020: 1-9.
19. Satici B, Gocet-Tekin E, Deniz ME, Satici SA. Adaptation of the fear of COVID-19 scale: its association with psychological distress and life satisfaction in Turkey. Int J Ment Health Addict 2021; 19: 1980-88.
20. Çiçek B, Şahin H, Erkal S. “Covid-19 Hijyen Ölçeği”: bir ölçek geliştirme çalışması. J Turk Stud 2020; 15: 339-50.
21. Xiong F, Tang H, Liu L, et al. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China. J Am Soc Nephrol 2020; 31: 1387-97.
22. Glass WG, Subbarao K, Murphy B, Murphy PM. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol 2004; 173: 4030-9.
23. Borges A, Borges M, Fernandes J, et al. Apoptosis of peripheral CD4(+) T-lymphocytes in end-stage renal disease patients under hemodialysis and rhEPO therapies. Ren Fail 2011; 33: 138-43.
24. Freitas GRR, da Luz Fernandes M, Agena F, et al. Aging and end stage renal disease cause a decrease in absolute circulating lymphocyte counts with a shift to a memory profile and diverge in treg population. Aging Dis 2019; 10: 49-61.
25. Tang B, Li S, Xiong Y, et al. COVID-19 Pneumonia in a hemodialysis patient. Kidney Med 2020; 2(3): 354-8.
26. Kapısız Ö, Eker F. Evaluation of the relationshipbetween the levels and perceptions of dyspnea and the levels of anxiety and depression in chronic obstructive pulmonary disease (COPD) patients. Psikiyatri Hemşireliği Derg 2018; 9: 88-95.
27. Sousa H, Ribeiro O, Costa E, et al. Being on hemodialysis during the COVID-19 outbreak: A mixed-methods' study exploring the impacts on dialysis adequacy, analytical data, and patients' experiences. Semin Dial 2021; 34: 66-76.
28. Li J, Xu G. Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis. Clin J Am Soc Nephrol 2020; 15: 717-9.
29. World Health Organization. (2020). WHO Coronavirus Disease (COVID-19) Dashboard. (Accessed July 9, 2020). Available at: https://covid19.who.int.
30. Wu H, Lau ESH, Ma RCW, et al. Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001-2016: a retrospective cohort study. Diabetologia 2020; 63: 757-66.
31. Booth CM, Matukas LM, Tomlinson GA, et al. Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA 2003; 289: 2801-9.
32. Chan JW, Ng CK, Chan YH, et al. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax 2003; 58: 686-9.
33. Badawi A, Ryoo SG. Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis 2016; 49: 129-33.
34. Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 2020; 94: 91-5.
35. Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol 2020; 17: 259-60.
36. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62.
37. Fram D, Okuno MF, Taminato M, et al. Risk factors for bloodstream infection in patients at a Brazilian hemodialysis center: a case-control study. BMC Infect Dis 2015; 15: 158.
38. Taş FS, Cengiz K, Erdem E, Karataş A, Kaya C. Akut ve Kronik böbrek yetmezliğinde mortalite nedenleri. Fırat Tıp Dergisi 2011; 16: 120-124.
39. Şanlıtürk D, Ovayolu N, Kes D. Hemodiyaliz hastalarında sık karşılaşılan problemler ve çözüm önerileri. Türk Nefroloji, Diyaliz ve Transplantasyon Hemşireleri Derneği Nefroloji Hemşireliği Derg 2018; 13: 17-25.
40. Harper AC, Satcell LP, Fido D, Latzman RD. Functional fear predicts public health compliance in the COVID-19 pandemic. Int J Ment Health Addict 2021; 19: 1875–88.